Heron Therapeutics Inc (NASDAQ:HRTX)

14.22
Delayed Data
As of Mar 27
 +0.23 / +1.64%
Today’s Change
6.51
Today|||52-Week Range
16.49
+41.35%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 23.00, with a high estimate of 40.00 and a low estimate of 20.00. The median estimate represents a +61.74% increase from the last price of 14.22.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.68
Sales
$0.00
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.66%
 
 
 
 
 
 
Growthannually -4.11%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account